Table 7: Subjects with Hb >11 g/dL, 12 g/dL, or Hb change ≥1 g/dL in Study 7 anytime from randomization to end of study (Safety Population).

1500 mg IV iron ()1000 mg IV iron ()Hazard ratio (95% CI)

(%) of patients with Hb >11 g/dL557 (56.1%)504 (51.1%)1.15 (1.02–1.30)
(%) of patients with Hb >12 g/dL358 (28.6%)251 (20.0%)1.44 (1.23–1.70)
(%) of patients with Hb change ≥1 g/dL610 (48.7%)513 (41.0%)1.27 (1.13–1.43)

Hb = hemoglobin.
Data on file, Luitpold Pharmaceuticals, Inc.